# Alnylam Pharmaceuticals, Inc.: Form 8-K, filed Sep 28, 2023

- Company: [Alnylam Pharmaceuticals, Inc.](/companies/alny.md) (CIK 1178670)
- Form: 8-K
- Filed: 2023-09-28
- Accepted by EDGAR: Sep 28, 2023, 17:00 ET
- Period: 2023-09-26
- Accession: 0001193125-23-245768
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1178670/000119312523245768/d477237d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1178670/000119312523245768/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1178670/000119312523245768/d477237d8k.htm

Filed Sep 28, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-245768. Last ingested by Listed: Nov 14, 2026, 23:27 ET. No prices; not investment advice.
